PubMed for id: 1728947

Year	Number of Results
1988	1
1995	2
1998	1
2000	2
2001	2
2002	2
2003	1
2006	1
2007	1
2008	1
2011	1
2012	5
2013	4
2014	6
2015	4
2016	8
2017	10
2018	13
2019	11
2020	11
2021	18
2022	18
2023	18
2024	7

1

Evolving patterns in systemic treatment utilization and survival among older patients with advanced cutaneous melanoma.

Hong YD, Enewold L, Sharon E, Warner JL, Davidoff AJ, Zeruto C, Mariotto AB. Hong YD, et al. Cancer Med. 2024 Aug;13(16):e70131. doi: 10.1002/cam4.70131. Cancer Med. 2024. PMID: 39194340 Free PMC article.

2

Efficacy of TIL therapy in advanced cutaneous melanoma in the current immuno-oncology era: updated systematic review and meta-analysis.

Martín-Lluesma S, Svane IM, Dafni U, Vervita K, Karlis D, Dimopoulou G, Tsourti Z, Rohaan MW, Haanen JBAG, Coukos G. Martín-Lluesma S, et al. Ann Oncol. 2024 Oct;35(10):860-872. doi: 10.1016/j.annonc.2024.07.723. Epub 2024 Jul 23. Ann Oncol. 2024. PMID: 39053767 Review.

3

Emerging prognostic biomarkers in advanced cutaneous melanoma: a literature update.

Roccuzzo G, Bongiovanni E, Tonella L, Pala V, Marchisio S, Ricci A, Senetta R, Bertero L, Ribero S, Berrino E, Marchiò C, Sapino A, Quaglino P, Cassoni P. Roccuzzo G, et al. Expert Rev Mol Diagn. 2024 Jan-Feb;24(1-2):49-66. doi: 10.1080/14737159.2024.2314574. Epub 2024 Feb 9. Expert Rev Mol Diagn. 2024. PMID: 38334382 Review.

4

A Review of Advanced Cutaneous Melanoma Therapies and Their Mechanisms, from Immunotherapies to Lysine Histone Methyl Transferase Inhibitors.

de Oliveira Filho RS, de Oliveira DA, Nisimoto MM, Marti LC. de Oliveira Filho RS, et al. Cancers (Basel). 2023 Dec 8;15(24):5751. doi: 10.3390/cancers15245751. Cancers (Basel). 2023. PMID: 38136297 Free PMC article. Review.

5

Immune checkpoint inhibitors in advanced cutaneous melanoma: a systematic review and meta-analysis of efficacy and review of characteristics.

Mahdiabadi S, Momtazmanesh S, Karimi A, Rezaei N. Mahdiabadi S, et al. Expert Rev Anticancer Ther. 2023 Jul-Dec;23(12):1281-1293. doi: 10.1080/14737140.2023.2278509. Epub 2023 Dec 8. Expert Rev Anticancer Ther. 2023. PMID: 37908134 Review.

6

Long-Term Temporal Trends in Survival Among Danish Patients with Advanced Cutaneous Melanoma: A Nationwide Follow-Up Study.

Pedersen AB, Johnsen SP, Horváth-Puhó E. Pedersen AB, et al. Clin Epidemiol. 2023 Jun 15;15:733-742. doi: 10.2147/CLEP.S407060. eCollection 2023. Clin Epidemiol. 2023. PMID: 37342868 Free PMC article.

7

Pigmentary retinopathy associated with immune therapy for advanced cutaneous melanoma.

Lin AC, Park SJ, Daniels GA, Borooah S. Lin AC, et al. Am J Ophthalmol Case Rep. 2023 Apr 18;30:101849. doi: 10.1016/j.ajoc.2023.101849. eCollection 2023 Jun. Am J Ophthalmol Case Rep. 2023. PMID: 37131528 Free PMC article.

8

Construction, validation and, visualization of a web-based nomogram to identify the best candidates for primary tumor resection in advanced cutaneous melanoma patients.

Li Z, Wei J, Zheng H, Zhang Y, Zhang Y, Cao H, Jin Y. Li Z, et al. Front Surg. 2023 Jan 18;9:975690. doi: 10.3389/fsurg.2022.975690. eCollection 2022. Front Surg. 2023. PMID: 36743900 Free PMC article.

9

Clinical feasibility and treatment outcomes with nonselected autologous tumor-infiltrating lymphocyte therapy in patients with advanced cutaneous melanoma.

Pillai M, Jiang Y, Lorigan PC, Thistlethwaite FC, Thomas M, Kirillova N, Bridgeman JS, Kueberuwa G, Biswas S, Velazquez P, Chonzi D, Guest RD, Roberts ZJ, Hawkins RE. Pillai M, et al. Am J Cancer Res. 2022 Aug 15;12(8):3967-3984. eCollection 2022. Am J Cancer Res. 2022. PMID: 36119832 Free PMC article.

10

Long Term Results and Prognostic Biomarkers for Anti-PD1 Immunotherapy Used after BRAFi/MEKi Combination in Advanced Cutaneous Melanoma Patients.

Rogala P, Czarnecka AM, Cybulska-Stopa B, Ostaszewski K, Piejko K, Ziętek M, Dziura R, Rutkowska E, Galus Ł, Kempa-Kamińska N, Seredyńska J, Bal W, Kozak K, Surus-Hyla A, Kubiatowski T, Kamińska-Winciorek G, Suwiński R, Mackiewicz J, Rutkowski P. Rogala P, et al. Cancers (Basel). 2022 Apr 24;14(9):2123. doi: 10.3390/cancers14092123. Cancers (Basel). 2022. PMID: 35565255 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

131 results

Results by year